Free Trial
The Market Does Not Wait. MarketBeat All Access Alerts for $149
Get the Alerts
Claim MarketBeat All Access Sale Promotion

Yousif Capital Management LLC Purchases 73,493 Shares of The Clorox Company $CLX

Clorox logo with Consumer Staples background
Image from MarketBeat Media, LLC.

Key Points

Yousif Capital Management LLC increased its position in shares of The Clorox Company (NYSE:CLX - Free Report) by 113.2% during the third quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 138,416 shares of the company's stock after acquiring an additional 73,493 shares during the period. Yousif Capital Management LLC owned about 0.11% of Clorox worth $11,213,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also bought and sold shares of the company. Studio Investment Management LLC grew its holdings in shares of Clorox by 2.2% during the third quarter. Studio Investment Management LLC now owns 8,081 shares of the company's stock worth $655,000 after purchasing an additional 171 shares during the last quarter. SeaCrest Wealth Management LLC increased its stake in shares of Clorox by 42.4% in the third quarter. SeaCrest Wealth Management LLC now owns 10,393 shares of the company's stock valued at $920,000 after buying an additional 3,095 shares during the period. NBT Bank N.A. bought a new position in Clorox in the 3rd quarter valued at approximately $313,000. SBI Securities Co. Ltd. raised its holdings in Clorox by 142.5% in the 3rd quarter. SBI Securities Co. Ltd. now owns 2,238 shares of the company's stock valued at $186,000 after buying an additional 1,315 shares during the last quarter. Finally, Pinnacle Bancorp Inc. raised its holdings in Clorox by 83.2% in the 3rd quarter. Pinnacle Bancorp Inc. now owns 513 shares of the company's stock valued at $42,000 after buying an additional 233 shares during the last quarter. Institutional investors and hedge funds own 78.53% of the company's stock.

Clorox Trading Down 2.6%

NYSE CLX opened at $86.38 on Friday. The firm has a market capitalization of $10.45 billion, a PE ratio of 17.92, a price-to-earnings-growth ratio of 2.87 and a beta of 0.59. The business's 50-day moving average price is $90.24 and its two-hundred day moving average price is $94.73. The company has a current ratio of 0.66, a quick ratio of 0.38 and a debt-to-equity ratio of 15.80. The Clorox Company has a 12 month low of $79.12 and a 12 month high of $128.90.

Clorox (NYSE:CLX - Get Free Report) last issued its quarterly earnings data on Monday, August 3rd. The company reported $1.66 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.64 by $0.02. Clorox had a return on equity of 522.23% and a net margin of 8.74%. The company had revenue of $1.95 billion during the quarter, compared to the consensus estimate of $1.91 billion. The firm's revenue was down 2.0% compared to the same quarter last year. During the same period last year, the company earned $2.87 earnings per share. Clorox has set its FY 2027 guidance at 5.700-6.000 EPS. On average, analysts expect that The Clorox Company will post 5.66 EPS for the current year.

Clorox Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, November 13th. Shareholders of record on Wednesday, October 28th will be given a dividend of $1.25 per share. This represents a $5.00 dividend on an annualized basis and a yield of 5.8%. The ex-dividend date of this dividend is Wednesday, October 28th. Clorox's dividend payout ratio is currently 103.73%.

Wall Street Analyst Weigh In

CLX has been the topic of several recent research reports. UBS Group set a $91.00 target price on shares of Clorox in a research report on Thursday, October 15th. Weiss Ratings restated a "hold (c-)" rating on shares of Clorox in a research report on Tuesday, October 6th. BNP Paribas Exane decreased their price target on shares of Clorox from $97.00 to $95.00 and set a "neutral" rating for the company in a research report on Monday, July 20th. Wells Fargo & Company dropped their price target on shares of Clorox from $90.00 to $85.00 and set an "equal weight" rating for the company in a research note on Monday, October 5th. Finally, TD Cowen cut their price target on shares of Clorox from $85.00 to $80.00 and set a "hold" rating on the stock in a report on Tuesday, October 13th. Twelve analysts have rated the stock with a Hold rating and four have assigned a Sell rating to the company. According to MarketBeat.com, Clorox has an average rating of "Reduce" and an average price target of $93.57.

View Our Latest Stock Report on CLX

Clorox Company Profile

(Free Report)

The Clorox Company, founded in 1913 and headquartered in Oakland, California, is a consumer and professional products company. It began with household bleach and has expanded into a portfolio of brands serving cleaning, household, personal care, food, and professional markets.

Its brands include Clorox disinfecting and cleaning products, Pine-Sol cleaners, Liquid-Plumr drain care, Kingsford charcoal, Fresh Step and Scoop Away cat litter, Hidden Valley dressings and dips, Brita water filtration products, and Burt's Bees personal care items.

Featured Stories

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Clorox Right Now?

Before you consider Clorox, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Clorox wasn't on the list.

While Clorox currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Don't Wait for the OpenAI IPO Cover

The AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines